Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex

Area of Science:

• Hepatology
• Immunology
• Virology

Background:

• Interleukin-1β (IL-1β) is a pro-inflammatory cytokine implicated in Hepatitis C virus (HCV) pathogenesis.
• Mechanisms of HCV-induced IL-1β activation and secretion were previously unclear.
• Inflammasome complexes are known to induce IL-1β in macrophages/monocytes.

Purpose of the Study:

• To identify the signaling pathway for IL-1β activation and secretion in HCV-infected human hepatoma cells.
• To investigate the role of the NALP3 inflammasome in HCV-induced IL-1β processing.
• To explore the involvement of reactive oxygen species in this pathway.

Main Methods:

• Infection of human hepatoma cells (JFH-1 strain) with HCV.
• Detection of NALP3-inflammasome complex assembly and IL-1β activation.
• Utilized small interfering RNA (siRNA) to assess inflammasome component roles.
• Measured reactive oxygen species generation.

Main Results:

• First report of NALP3-inflammasome complex induction and assembly in HCV-infected human hepatoma cells.
• Demonstrated proteolytic processing of pro-caspase-1 to mature caspase-1 within the inflammasome.
• Confirmed HCV sensing by NALP3, leading to ASC recruitment and inflammasome assembly.
• Showed inflammasome components are essential for IL-1β activation in HCV infection.
• Identified a role for reactive oxygen species in HCV-induced IL-1β secretion.

Conclusions:

• Elucidated a novel signaling pathway for IL-1β processing and secretion in HCV-infected liver cells.
• The NALP3 inflammasome, ASC, and reactive oxygen species are key mediators.
• Findings offer potential targets for therapeutic strategies against chronic HCV-associated liver disease.